Traduction de «costs » (Néerlandais → Français) :

Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and bupropion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.
Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and Buproprion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.

These impacts however were more than offset by a number of positive factors, including: Marketing & Sales costs, which were lower by 0.4 percentage points due to productivity improvements partly offset by investments in growth areas; R&D costs, which decreased (improving +1.2 percentage points) as productivity savings funded continued investment in the development of differentiated generics; General & Administration costs, which decreased (+1.1 percentage points) due to ongoing cost reduction measures; and Other Income and Expenses, which were positive at 0.5 percentage points due to lower legal fees.
Cependant, ces impacts ont été plus que compensés par un certain nombre de facteurs positifs, notamment: une baisse de 0,4 point de pourcentage des coûts de Marketing et vente due à des gains de productivité en partie contrebalancés par des investissements dans des domaines en pleine croissance; une diminution des coûts de Recherche et développement (amélioration +1,2 point), des gains de productivité servant à financer des investissements continus dans le développement de génériques différenciés; un abaissement des coûts d’Administration et frais généraux (+1,1 point) grâce à des mesures continues de réduction des coûts; une progression de 0,5 point d'Autres produits et charges suite à une baisse des frais juridiques.

MeSH: Radiotherapy; Cost and Cost Analysis
MeSH : Radiotherapy; Cost and Cost Analysis.

Estimated cost of bupropion is similar to the estimated cost of NRT GP advice can be opportunistic, i.e. given during a consultation primarily concerned with another health matter.
Estimated cost of Buproprion is similar to the estimated cost of NRT GP advice can be opportunistic, i.e. given during a consultation primarily concerned with another health matter.

MeSH : Cost-Benefit Analysis ; Decision Making ; Health Care Rationing / economics ; Quality- Adjusted Life Years ; Health Care Costs
MeSH: Cost-Benefit Analysis ; Decision Making ; Health Care Rationing / economics ; Quality- Adjusted Life Years ; Health Care Costs

Corporate income & expense, net Corporate income & expense, which includes the costs of the Group headquarters and costs for corporate research, was impacted by one-time stamp duty and transaction expenses related to the purchase of the additional 52% of Alcon shares of USD 96 million in the third quarter.
Produits/charges nets de Corporate Produits et charges de Corporate, qui comprennent les coûts du siège du Groupe et ceux de la recherche Corporate, ont été impactés par un droit de timbre non récurrent et des frais de transaction liés à l'acquisition, au troisième trimestre, des 52% supplémentaires d'actions Alcon pour USD 96 millions.

General & Administration costs (3.7% of net sales; +1.4 percentage points) decreased due to ongoing cost-containment measures.
Administration et frais généraux (3,7% du chiffre d’affaires net, +1,4 point) ont diminué grâce aux mesures de réduction des coûts en cours.

o Nieuwe financieringsmodellen, incl. activity-based costing
o Nouveaux modes de financement, dont activity-based costing

Volgens de NICE normen waren de resultaten relatief ongunstig en " de Commissie besloot dat de meest plausibele ICER (incremental cost-effectiveness ratio - incrementele kosteneffectiviteitsratio) voor bevacizumab in combinatie met paclitaxel ten opzichte van wekelijkse paclitaxel tussen £110,000 en £259,000 per gewonnen QALY schommelde" .
Conformément aux standards du NICE, les résultats ont été relativement défavorables et " le Comité a conclu que l'ICER (incremental cost-effectiveness ratio – ratio cout efficacité incrémental) le plus plausible du bevacizumab plus paclitaxel versus du paclitaxel toutes les semaines se situait entre £110,000 et £259,000 par QALY gagné”.

Innovatieve radiotherapie-technieken: een multicenter time-driven activity-based costing studie | KCE
Techniques innovantes en radiothérapie : une étude multicentrique d’évaluation du cout via la méthode ABC pilotée par le temps | KCE